The Urology Group

Cincinnati, Ohio 45212

We've found

1 trials

at this facility

An Open-label Study Examining the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (CRPC)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Cincinnati, OH

Use our guide to learn which trials are right for you!